Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Cryptic noncanonical splice site activation is part of the mechanism that abolishes multimer organization in the c.2269_2270del von Willebrand factor.

Daidone V, Galletta E, De Marco L, Casonato A.

Haematologica. 2019 Jul 18. pii: haematol.2019.222679. doi: 10.3324/haematol.2019.222679. [Epub ahead of print]

2.

The elusive and heterogeneous pattern of type 2M von Willebrand disease: A diagnostic challenge.

Casonato A, Galletta E, Daidone V.

Eur J Haematol. 2018 Aug 6. doi: 10.1111/ejh.13159. [Epub ahead of print]

PMID:
30084138
3.

Type 3 von Willebrand disease mistaken for moderate haemophilia A: a lesson still to be learned.

Galletta E, Daidone V, Zanon E, Casonato S.

Haemophilia. 2018 May;24(3):e154-e157. doi: 10.1111/hae.13490. Epub 2018 Apr 17. No abstract available.

PMID:
29665224
4.

A Mechanistic Model to Quantify von Willebrand Factor Release, Survival and Proteolysis in Patients with von Willebrand Disease.

Ferrari M, Galvanin F, Barolo M, Daidone V, Padrini R, Bezzo F, Casonato A.

Thromb Haemost. 2018 Feb;118(2):309-319. doi: 10.1160/TH17-05-0375. Epub 2018 Jan 29.

PMID:
29378356
5.

Type 1 von Willebrand disease due to a vicinal cysteine loss (p.C524Y) disclosed after a thrombotic episode.

Daidone V, Galletta E, Casonato A.

Thromb Res. 2018 Jan;161:91-93. doi: 10.1016/j.thromres.2017.11.021. Epub 2017 Nov 26. No abstract available.

PMID:
29220693
6.

Type 2N von Willebrand disease: Characterization and diagnostic difficulties.

Casonato A, Galletta E, Sarolo L, Daidone V.

Haemophilia. 2018 Jan;24(1):134-140. doi: 10.1111/hae.13366. Epub 2017 Nov 8.

PMID:
29115006
7.

Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue.

Casonato A, Daidone V, Galletta E, Bertomoro A.

PLoS One. 2017 Jun 22;12(6):e0179566. doi: 10.1371/journal.pone.0179566. eCollection 2017.

8.

The Bleeding Assessment Tool and laboratory data in the characterisation of a female with inherited haemophilia A.

Daidone V, Galletta E, Bertomoro A, Casonato A.

Blood Transfus. 2018 Jan;16(1):114-117. doi: 10.2450/2016.0132-16. Epub 2016 Nov 15. No abstract available.

9.

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease.

Casonato A, Cattini MG, Daidone V, Pontara E, Bertomoro A, Prandoni P.

PLoS One. 2016 Aug 17;11(8):e0161310. doi: 10.1371/journal.pone.0161310. eCollection 2016.

10.

Two novel ITGA2B mutations in a Glanzmann thrombasthaenia family associated with different platelet phenotypic expression.

Daidone V, Bury L, Milan M, Galletta E, Gresele P, Casonato A.

Blood Transfus. 2017 Sep;15(5):487-488. doi: 10.2450/2016.0055-16. Epub 2016 Jul 12. No abstract available.

11.

Haemostatic patterns and bleeding scores of a genetically characterised Italian family with combined haemophilia A and type 1 von Willebrand disease.

Daidone V, Pontara E, Boscaro F, Cattini MG, Milan M, Casonato A.

Blood Coagul Fibrinolysis. 2017 Apr;28(3):230-233. doi: 10.1097/MBC.0000000000000583.

PMID:
27380589
12.

Usefulness of the Total Thrombus-Formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease.

Daidone V, Barbon G, Cattini MG, Pontara E, Romualdi C, Di Pasquale I, Hosokawa K, Casonato A.

Haemophilia. 2016 Nov;22(6):949-956. doi: 10.1111/hae.12971. Epub 2016 Jun 13.

PMID:
27293213
13.

Higher and lower active circulating VWF levels: different facets of von Willebrand disease.

Casonato A, Pontara E, Morpurgo M, Sartorello F, De Groot PG, Cattini MG, Daidone V, De Marco L.

Br J Haematol. 2015 Dec;171(5):845-53. doi: 10.1111/bjh.13785. Epub 2015 Oct 12.

PMID:
26456374
14.

Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534-3C>A von Willebrand factor mutation.

Casonato A, Cattini MG, Barbon G, Daidone V, Pontara E.

Thromb Res. 2015 Sep;136(3):682-6. doi: 10.1016/j.thromres.2015.07.014. Epub 2015 Jul 26.

PMID:
26251079
15.

A venous thromboembolism risk assessment model for patients with Cushing's syndrome.

Zilio M, Mazzai L, Sartori MT, Barbot M, Ceccato F, Daidone V, Casonato A, Saggiorato G, Noventa F, Trementino L, Prandoni P, Boscaro M, Arnaldi G, Scaroni C.

Endocrine. 2016 May;52(2):322-32. doi: 10.1007/s12020-015-0665-z. Epub 2015 Jun 26.

PMID:
26113424
16.

The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.

Daidone V, Saga G, Barbon G, Pontara E, Cattini MG, Morpurgo M, Zanotti G, Casonato A.

Br J Haematol. 2015 Aug;170(4):564-73. doi: 10.1111/bjh.13472. Epub 2015 Apr 23.

PMID:
25904363
17.

Perioperative thromboprophylaxis in Cushing's disease: What we did and what we are doing?

Barbot M, Daidone V, Zilio M, Albiger N, Mazzai L, Sartori MT, Frigo AC, Scanarini M, Denaro L, Boscaro M, Casonato S, Ceccato F, Scaroni C.

Pituitary. 2015 Aug;18(4):487-93. doi: 10.1007/s11102-014-0600-y.

PMID:
25239557
18.

Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor.

Daidone V, Barbon G, Pontara E, Cattini GM, Gallinaro L, Zampese E, Pizzo P, Casonato A.

Thromb Haemost. 2014 Dec;112(6):1159-66. doi: 10.1160/TH14-04-0391. Epub 2014 Sep 18.

PMID:
25230768
19.

Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease.

Pontara E, Gresele P, Cattini MG, Daidone V, Barbon G, Girolami A, Zanon E, Casonato A.

Blood Coagul Fibrinolysis. 2014 Jun;25(4):401-4. doi: 10.1097/MBC.0000000000000067.

PMID:
24418945
20.

Diagnosis and complications of Cushing's disease: gender-related differences.

Zilio M, Barbot M, Ceccato F, Camozzi V, Bilora F, Casonato A, Frigo AC, Albiger N, Daidone V, Mazzai L, Mantero F, Scaroni C.

Clin Endocrinol (Oxf). 2014 Mar;80(3):403-10. doi: 10.1111/cen.12299. Epub 2013 Sep 4.

PMID:
23889360
21.

C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor.

Casonato A, Pontara E, Battiston M, Morpurgo M, Cattini MG, Casarin E, Saga G, Daidone V, De Marco L.

Thromb Haemost. 2013 Jun;109(6):999-1006. doi: 10.1160/TH12-11-0808. Epub 2013 Feb 28.

PMID:
23446343
22.

A common ancestor more than 10,000 years old for patients with R854Q-related type 2N von Willebrand's disease in Italy.

Casonato A, Daidone V, Barbon G, Pontara E, Di Pasquale I, Gallinaro L, Marullo L, Bertorelle G.

Haematologica. 2013 Jan;98(1):147-52. doi: 10.3324/haematol.2012.066019. Epub 2012 Aug 8.

23.

Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile.

Koutroumpi S, Daidone V, Sartori MT, Cattini MG, Albiger NM, Occhi G, Ferasin S, Frigo A, Mantero F, Casonato A, Scaroni C.

Pituitary. 2013 Jun;16(2):175-81. doi: 10.1007/s11102-012-0398-4.

PMID:
22585010
24.

Assessment of von Willebrand factor propeptide improves the diagnosis of von Willebrand disease.

Casonato A, Daidone V, Padrini R.

Semin Thromb Hemost. 2011 Jul;37(5):456-63. doi: 10.1055/s-0031-1281029. Epub 2011 Nov 18. Review.

PMID:
22102187
25.

von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding.

Casonato A, Sponga S, Pontara E, Cattini MG, Basso C, Thiene G, Cella G, Daidone V, Gerosa G, Pagnan A.

Thromb Haemost. 2011 Jul;106(1):58-66. doi: 10.1160/TH10-10-0634. Epub 2011 May 5.

PMID:
21544311
26.

An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease.

Daidone V, Gallinaro L, Grazia Cattini M, Pontara E, Bertomoro A, Pagnan A, Casonato A.

Haematologica. 2011 Jun;96(6):881-7. doi: 10.3324/haematol.2010.036848. Epub 2011 Mar 10.

27.

New insight into the hypercoagulability of Cushing's syndrome.

Daidone V, Boscaro M, Pontara E, Cattini MG, Occhi G, Scaroni C, Mantero F, Casonato A.

Neuroendocrinology. 2011;93(2):121-5. doi: 10.1159/000323765. Epub 2011 Feb 8.

28.

Coagulopathy in Cushing's syndrome.

Trementino L, Arnaldi G, Appolloni G, Daidone V, Scaroni C, Casonato A, Boscaro M.

Neuroendocrinology. 2010;92 Suppl 1:55-9. doi: 10.1159/000314349. Epub 2010 Sep 10. Review.

29.

Hypercortisolism and pregnancy upregulate von Willebrand factor through different mechanisms: report on a pregnant patient with Cushing's syndrome.

Casonato A, Daidone V, Pontara E, Albiger N, Cattini MG, Scaroni C.

Blood Coagul Fibrinolysis. 2010 Jul;21(5):476-9.

PMID:
20614575
30.

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia.

Casonato A, Gallinaro L, Cattini MG, Pontara E, Padrini R, Bertomoro A, Daidone V, Pagnan A.

Haematologica. 2010 Aug;95(8):1366-72. doi: 10.3324/haematol.2009.019927. Epub 2010 Mar 19.

31.

Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series.

Casonato A, Gallinaro L, Cattini MG, Sartorello F, Pontara E, Padrini R, Bertomoro A, Daidone V, Pagnan A.

Transl Res. 2010 Apr;155(4):200-8. doi: 10.1016/j.trsl.2009.12.003. Epub 2009 Dec 30.

PMID:
20303469
32.

Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome.

Daidone V, Pontara E, Romualdi C, Cattini MG, Scaroni C, Albiger N, Pagnan A, Casonato A.

Thromb Res. 2010 Jun;125(6):e275-80. doi: 10.1016/j.thromres.2010.01.031. Epub 2010 Feb 13.

PMID:
20156642
33.

Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions.

Daidone V, Cattini MG, Pontara E, Sartorello F, Gallinaro L, Marotti A, Scaroni C, Pagnan A, Casonato A.

Thromb Haemost. 2009 Feb;101(2):298-304.

PMID:
19190813
34.

Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease.

Sztukowska M, Gallinaro L, Cattini MG, Pontara E, Sartorello F, Daidone V, Padrini R, Pagnan A, Casonato A.

Br J Haematol. 2008 Oct;143(1):107-14. doi: 10.1111/j.1365-2141.2008.07311.x. Epub 2008 Aug 7.

PMID:
18691167
35.

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor.

Gallinaro L, Cattini MG, Sztukowska M, Padrini R, Sartorello F, Pontara E, Bertomoro A, Daidone V, Pagnan A, Casonato A.

Blood. 2008 Apr 1;111(7):3540-5. doi: 10.1182/blood-2007-11-122945. Epub 2008 Feb 1.

36.

Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome.

Casonato A, Daidone V, Sartorello F, Albiger N, Romualdi C, Mantero F, Pagnan A, Scaroni C.

Br J Haematol. 2008 Jan;140(2):230-5. doi: 10.1111/j.1365-2141.2007.06907.x.

PMID:
18173757
37.

A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis.

Casonato A, Sartorello F, Pontara E, Gallinaro L, Bertomoro A, Grazia Cattini M, Daidone V, Szukowska M, Pagnan A.

Thromb Haemost. 2007 Dec;98(6):1182-7.

PMID:
18064311
38.

Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease.

Casonato A, Gallinaro L, Pontara E, Bernardo L, Sartorello F, Daidone V, Pagnan A.

Thromb Res. 2007;120(3):451-3. Epub 2006 Dec 15. No abstract available.

PMID:
17157361

Supplemental Content

Loading ...
Support Center